Zacks Small Cap Research on MSN
LEXX: Dosing started for animal & human GLP-1 studies
By John Vandermosten, CFA NASDAQ: LEXX READ THE FULL LEXX RESEARCH REPORT We update our report on Lexaria Bioscience ...
Want to be a doctor, dentist, optometrist, pharmacist, ecologist, genetic counselor, or a professor? Do you want to cure cancer, Ebola, or Alzheimer’s disease? Maybe you want to help endangered ...
ASCENTRA-UC expected to enroll up to 204 patients with moderately to severely active ulcerative colitis across North America and Europe First patient enrollment anticipated in the second half of 2026; ...
The Notes will be general unsecured obligations of Nuvation Bio, with any interest payable semiannually in arrears and will mature on July 1, 2032, unless earlier converted, redeemed or repurchased.
Clive Davis' No. 1 hits on the Billboard Hot 100 include songs by Whitney Houston, Barry Manilow, Simon & Garfunkel, Usher ...
Sanofi says it has reached an agreement with Dren Bio that would see it take control of autoimmune disease treatment DR-0201, a bispecific antibody-based myeloid cell engager with the potential to ...
Shares of Ataibeckley Inc. (NASDAQ:ATAI) were trading at $7.12, up $1.75, or 32%, on word that Eli Lilly and Co. is taking over the psychedelics firm for $6.75 per share in cash upon closing plus up ...
Thomas Tuchel has made some bold decisions when selecting the 26-man party that England have taken to the World Cup with the likes of Phil Foden and Cole Palmer missing. Trent Alexander Arnold also ...
Breakthrough T1D, the leading global type 1 diabetes (T1D) research and advocacy organization and SAB Biotherapeutics, Inc. (Nasdaq: SABS), a clinical-stage biopharmaceutical company developing a ...
Highlights combined company's strong financial position with over $900 million expected at closing, Treeline's deep clinical-stage pipeline, planned 2027 data updates for TLN-121 and TLN-372, and expe ...
Agreement provides Incyte the rights to develop and commercialize ENHANZE® with its mutCALR development program and an option to nominate up to two additional targets ...
U.S. 3 Year Treasury Note 0.0070 4.2490% U.S. 5 Year Treasury Note 0.0040 4.3210% U.S. 7 Year Treasury Note 0.0070 4.4500% ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果